Overexpression of mutant EGFR protein indicates a better survival benefit from EGFR-TKI therapy in non-small cell lung cancer

Yun Ling(Zhejiang Chinese Medical University), Dongmei Lin(Chinese Academy of Medical Sciences & Peking Union Medical College)
Oncotarget
July 13, 2016
Cited by 10


Related Papers